This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
APO-Norflox 400 mg (2015-08-25)
- Starting date:
- August 25, 2015
- Posting date:
- August 31, 2015
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-54836
Affected Products
APO-Norflox 400 mg
Reason
Levels of excipients crospovidone and magnesium stereate do not meet the quantities specified in the regulatory filing.
Depth of distribution
Wholesalers, Distributors, and Retailers
Affected products
APO-Norflox 400 mg
DIN, NPN, DIN-HIM
DIN 02229524Dosage form
Tablet
Strength
Norfloxacin 400 mg
Lot or serial number
MC8181
Companies
- Recalling Firm
-
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
- Marketing Authorization Holder
-
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA